Park Medi World Ltd

Park Medi World Ltd announced that its wholly-owned subsidiary, Umkal Health Care Private Limited, has approved the expansion of its existing 225-bed Park Hospital in Palam Vihar, Gurugram, by adding 100 new beds. The expanded facility, to be branded as Park Hospital Platinum, is expected to commence operations in November 2026. This expansion will increase Park Group's consolidated bed capacity in Gurugram to 750 beds and will focus on bolstering super-specialty capabilities. The Palam Vihar facility, which had an occupancy of ~86% and generated revenue of ~INR 245 crs in FY'26, is a flagship hospital for the group. This move reinforces Park Group's commitment to strengthening healthcare infrastructure and leadership in North India.

Park Medi World Limited has announced the closure of its trading window for designated persons and their immediate relatives. The window will be shut from Wednesday, July 01, 2026, until 48 hours after the announcement of the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. The specific date for the Board Meeting to approve these financial results will be communicated later. The company has also made this intimation available on its website.

Park Medi World Ltd, through its wholly owned subsidiary Aggarwal Hospital and Research Services Private Limited, has approved the divestment of its 55% shareholding in Devina Derma Private Limited for INR 0.06 crore. This strategic move aims to streamline the corporate structure and focus resources on core priorities. The divestment follows the failure of sellers to meet pre-requisite conditions. Devina Derma's turnover was INR 0.45 crore (0.03% of consolidated turnover) with a negative net worth of INR (0.34) as of March 31, 2026. The transaction is expected to be completed on June 05, 2026, with the buyer being Zen Zone Healthcare Private Limited, which is not a promoter or group company.

Park Medi World Ltd has announced the acquisition of V3 Healthcare Private Limited, which operates The Medicity Hospital in Rudrapur, Uttarakhand. The acquisition, valued at approximately ₹177 Crores, will be completed in two tranches, with 80% of the shareholding acquired by August 31, 2026, and the remaining 20% by April 30, 2030. The Medicity Hospital is a 330-bed multi-super speciality hospital with a turnover of ₹55.74 crores for FY 2025-26. This acquisition aligns with Park Medi World's growth strategy to expand in high-potential markets.

Park Medi World Ltd has announced the acquisition of V3 Healthcare Private Limited, which operates The Medicity Hospital in Rudrapur, Uttarakhand. The acquisition involves acquiring 80% of the shareholding by August 31, 2026, and the remaining 20% by April 30, 2030, for a total consideration of approximately ₹177 Crores in cash. The Medicity Hospital is a 330-bed multi-super speciality hospital with a turnover of ₹55.74 crores for FY 2025-26.

Park Medi World Ltd's subsidiary, Park Medicenters and Institutions Private Limited, has incorporated a wholly-owned subsidiary named Healplus Medical Services Private Limited on May 20, 2026. Healplus will focus on healthcare services, including retail and wholesale of pharmaceuticals, medicines, and healthcare products. The incorporation aims to diversify and expand Park Medi World's current business operations. Park Medicenters will infuse subscribed share capital in cash, with a cost of acquisition of ₹0.01 crore.

Park Medi World Ltd has released the Monitoring Agency Report by CRISIL Ratings Limited for the quarter ended March 31, 2026, regarding the utilization of IPO proceeds. The report, as per Regulation 32(6) and 41(4) of SEBI regulations, was reviewed by the Board of Directors and Audit Committee on May 15, 2026. The IPO issue size was ₹7,700 million, with net proceeds of ₹7,132.77 million after deducting issue expenses of ₹567.23 million. The monitoring agency confirmed that the utilization of funds is in accordance with the Offer Document.

Park Medi World Ltd has announced the uploading of Key Performance Indicators (KPIs) as defined under the Prospectus dated December 12, 2025, filed with ROC, SEBI, and Stock Exchanges. The KPIs are now accessible on the company's website at https://www.parkhospital.in/. This disclosure is made in compliance with SEBI regulations.

Park Medi World Ltd's board meeting on May 15, 2026, approved the appointment of Sachin Gupta & Co. as Cost Auditor, NKSC & Co. as Internal Auditor, and SBR & Co. as Secretarial Auditor. SBR & Co.'s appointment is subject to shareholder approval at the upcoming AGM and is for a 5-year term. The meeting commenced at 4:00 P.M. (IST) and concluded at 4:57 P.M. (IST).

Park Medi World Ltd's Board of Directors, in its meeting on May 15, 2026, approved the appointment of Sachin Gupta & Co. as Cost Auditor, NKSC & Co. as Internal Auditor for FY 2026-27, and SBR & Co. as Secretarial Auditor for FY 2025-26 to 2029-30, subject to shareholder approval. The board meeting commenced at 04:00 P.M. (IST) and concluded at 04:57 P.M. (IST).